NEWS - Apr 13, 2017 Relmada Announces FDA Fast Track Designation for d-Methadone for Adjunctive Treatment of Major Depressive Disorder Read more
NEWS - Feb 15, 2017 Relmada Therapeutics to Participate in the 2nd Annual Disruptive Growth & Healthcare Conference Read more
NEWS - Jan 25, 2017 Relmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone Read more
NEWS - Jan 24, 2017 Relmada Therapeutics to Provide an Update on the Development Plan for LevoCap ER Read more
NEWS - Nov 29, 2016 Relmada Therapeutics to Present at LD Micro "Main Event" Investor Conference Read more
NEWS - Oct 27, 2016 Relmada Therapeutics to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention Read more
NEWS - Oct 19, 2016 Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms Read more
